We are live on
!
Find out more
PC
Pier Capital Portfolio holdings
AUM
$755M
1-Year Est. Return
94.38%
This Fund
S&P 500
This Quarter
Est. Return
-5.19%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$620M
AUM Growth
-$76.6M
(-11%)
Cap. Flow
-$23.1M
Cap. Flow
% of AUM
-3.73%
Top 10 Holdings %
Top 10 Hldgs %
18.12%
Holding
124
New
9
Increased
28
Reduced
73
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Grocery Outlet
GO
|
+$7.8M |
| 2 |
LiveRamp
RAMP
|
+$6.8M |
| 3 |
Advanced Drainage Systems
WMS
|
+$5.56M |
| 4 |
Crocs
CROX
|
+$4.45M |
| 5 |
Lindblad Expeditions
LIND
|
+$4.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AKRO
Akero Therapeutics
AKRO
|
+$6.9M |
| 2 |
Globant
GLOB
|
+$6.68M |
| 3 |
Doximity
DOCS
|
+$6.43M |
| 4 |
Itron
ITRI
|
+$6.02M |
| 5 |
Seacoast Banking Corp of Florida
SBCF
|
+$5.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 22.14% |
| 3 | Industrials | 19.66% |
| 4 | Consumer Discretionary | 11.4% |
| 5 | Consumer Staples | 7.36% |
Similar funds
HCM
FSCM
RMC
BEC
MWA
TPW
OM
MGM
Pier Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Pier Capital held 124 positions worth $620M, down 11% from $697M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Pier Capital withdrew a net $23.1M in Q3 2023, closing 6 positions and reducing 73 holdings. Its most notable exit was Akero Therapeutics, an estimated $6.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Pier Capital opened a new position in Grocery Outlet worth $7.07M.
- Pier Capital's largest Q3 2023 buy was Grocery Outlet: 245,066 shares worth $7.07M.
- Pier Capital added most to Lindblad Expeditions in Q3 2023, an estimated $4.39M increase.
- Pier Capital's biggest Q3 2023 reduction was Globant, cutting an estimated $6.68M.
- Pier Capital fully exited Akero Therapeutics in Q3 2023, selling an estimated $6.9M.
- Pier Capital's ten largest holdings make up 18% of its $620M portfolio in Q3 2023.
- Pier Capital opened 9 new positions and closed 6 in Q3 2023.
- Pier Capital's portfolio value fell 11% quarter-over-quarter to $620M.
Based on Pier Capital's 13F filing for Q3 2023, filed 14 Nov 2023.